dbo:abstract |
Glycopyrronium bromide/formoterol, sold under the brand name Bevespi Aerosphere, is a combination medication for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is a combination of glycopyrronium bromide and formoterol. It is inhaled. The most common side effects include headache, nausea (feeling sick), muscle spasms and dizziness. Glycopyrronium bromide is a muscarinic receptor antagonist. This means that it blocks muscarinic receptors (targets) in muscle cells in the lungs. Because these receptors help control the contraction of muscles, when glycopyrronium is inhaled, it causes the muscles of the airways to relax, helping to keep the airways open. Formoterol is a long-acting beta-2 agonist. It works by attaching to receptors known as beta-2 receptors found in the muscles of the airways. When it attaches to these receptors, it causes the muscles to relax, which keeps the airways open. (en) |
dbo:alternativeName |
Bevespi Aerosphere (en) |
dbo:kegg |
D11036 |
dbo:wikiPageExternalLink |
https://medlineplus.gov/druginfo/meds/a602023.html https://druginfo.nlm.nih.gov/drugportal/name/formoterol https://druginfo.nlm.nih.gov/drugportal/rn/51186-83-5 https://medlineplus.gov/druginfo/meds/a618016.html |
dbo:wikiPageID |
63896478 (xsd:integer) |
dbo:wikiPageLength |
6986 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID |
1093846231 (xsd:integer) |
dbo:wikiPageWikiLink |
dbc:Beta2-adrenergic_agonists dbr:Oral_administration dbr:Chronic_obstructive_pulmonary_disease dbr:Glycopyrronium_bromide dbr:Anticholinergic dbr:Long-acting_beta-adrenoceptor_agonist dbc:Muscarinic_antagonists dbr:Formoterol dbc:AstraZeneca_brands dbc:Combination_drugs dbr:Muscarinic |
dbp:atcPrefix |
R03 (en) |
dbp:atcSuffix |
AL07 (en) |
dbp:class |
dbr:Anticholinergic dbr:Long-acting_beta-adrenoceptor_agonist dbr:Muscarinic |
dbp:component |
Formoterol (en) Glycopyrronium bromide (en) |
dbp:dailymedid |
Glycopyrrolate_and_formoterol (en) |
dbp:kegg |
D11036 (en) |
dbp:legalCa |
Rx-only (en) |
dbp:legalEu |
Rx-only (en) |
dbp:legalStatus |
Rx-only (en) |
dbp:legalUs |
Rx-only (en) |
dbp:routesOfAdministration |
dbr:Oral_administration |
dbp:tradename |
Bevespi Aerosphere (en) |
dbp:type |
combo (en) |
dbp:wikiPageUsesTemplate |
dbt:Cite_journal dbt:Cite_web dbt:Infobox_drug dbt:Portal_bar dbt:Reflist dbt:Short_description dbt:Use_American_English dbt:Use_dmy_dates dbt:Drugs.com dbt:AstraZeneca dbt:Drugs_for_obstructive_airway_diseases |
dct:subject |
dbc:Beta2-adrenergic_agonists dbc:Muscarinic_antagonists dbc:AstraZeneca_brands dbc:Combination_drugs |
rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:CombinationDrug dbo:Drug |
rdfs:comment |
Glycopyrronium bromide/formoterol, sold under the brand name Bevespi Aerosphere, is a combination medication for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is a combination of glycopyrronium bromide and formoterol. It is inhaled. The most common side effects include headache, nausea (feeling sick), muscle spasms and dizziness. (en) |
rdfs:label |
Glycopyrronium bromide/formoterol (en) |
owl:sameAs |
wikidata:Glycopyrronium bromide/formoterol https://global.dbpedia.org/id/BvvBU |
prov:wasDerivedFrom |
wikipedia-en:Glycopyrronium_bromide/formoterol?oldid=1093846231&ns=0 |
foaf:isPrimaryTopicOf |
wikipedia-en:Glycopyrronium_bromide/formoterol |
is dbo:wikiPageRedirects of |
dbr:Bevespi dbr:Bevespi_Aerosphere dbr:Glycopyrrolate/formoterol dbr:Glycopyrrolate/formoterol_fumarate dbr:Glycopyrronium,_formoterol_fumarate_dihydrate dbr:Glycopyrronium/formoterol_fumarate_dihydrate dbr:Glycopyrronium_bromide/formoterol_fumarate_dihydrate dbr:Formoterol/glycopyrronium_bromide |
is dbo:wikiPageWikiLink of |
dbr:Bevespi dbr:Bevespi_Aerosphere dbr:Budesonide/glycopyrronium_bromide/formoterol dbr:ATC_code_R03 dbr:Glycopyrrolate/formoterol dbr:Glycopyrrolate/formoterol_fumarate dbr:Glycopyrronium,_formoterol_fumarate_dihydrate dbr:Glycopyrronium/formoterol_fumarate_dihydrate dbr:Glycopyrronium_bromide/formoterol_fumarate_dihydrate dbr:Formoterol/glycopyrronium_bromide |
is foaf:primaryTopic of |
wikipedia-en:Glycopyrronium_bromide/formoterol |